| Code | 3615D | ||||||||||
| MA number | 68/0033/20-S | ||||||||||
| Product Form: | tbl plg 60x600 mg (blis.PVC/PCTFE/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Neuraxpharm Bohemia s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 30 | ||||||||||
| Container: | blister PVC/PCTFE/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 21.02.2020 |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Questax XR 600mg_07_2024.pdf
|
| PIL: |
PIL_Questax XR 600mg_07_2024.pdf
|
| Safety feature | Yes |
| Data update: | 22.05.2024 |
